FJ Labs

FJ Labs, established in 2015 and headquartered in New York, is a stage-agnostic investment firm focusing on marketplaces and consumer-facing startups. It invests in seed and series A rounds, with a typical investment range of $50,000 to $5,000,000. The firm's portfolio includes notable companies such as Alibaba Group, Beepi, BrightRoll, Betterment, Adore Me, and Earnest, spanning sectors like e-commerce, fintech, and ad tech.

Matias Barbero

Venture Capital

Zineb Belghiti

Operations Associate

William Guillouard

Operating Partner

Arne Halleraker

Partner

Christopher Keshian

Investor

Ariel Lebowits

CFO

Jose Marin

Founding Partner

Güimar Vaca Sittic

Venture Partner

Jeff Weinstein

Partner

Past deals in Austria

Samsara Therapeutics

Convertible Note in 2024
Samsara Therapeutics, founded in 2018 with operations across Europe and San Diego, is a biopharmaceutical company dedicated to discovering and developing therapeutics for age-related diseases and unmet medical needs. Its proprietary platform focuses on identifying and validating compounds that extend healthy lifespan by targeting fundamental aging processes such as proteostasis and autophagy. The company aims to create novel treatments for rare genetic and neurodegenerative diseases through its pipeline, which involves compound identification, chemical optimization, and in vivo validation across various species.

Refurbed

Series C in 2023
Refurbed GmbH is an online marketplace based in Vienna, Austria, specializing in the distribution of refurbished electronic goods. Founded in 2017, the company offers a range of products including phones, TVs, tablets, smart watches, laptops, desktops, headphones, consoles, cameras, and kitchen appliances. Refurbed devices undergo a rigorous 40-step renewal process to ensure they look new and function like new. Each device comes with at least a 12-month guarantee. The company aims to provide products that are up to 40% cheaper and 100% more environmentally friendly than brand-new counterparts, making it an attractive option for cost-conscious and eco-friendly consumers.

Samsara Therapeutics

Series A in 2022
Samsara Therapeutics, founded in 2018 with operations across Europe and San Diego, is a biopharmaceutical company dedicated to discovering and developing therapeutics for age-related diseases and unmet medical needs. Its proprietary platform focuses on identifying and validating compounds that extend healthy lifespan by targeting fundamental aging processes such as proteostasis and autophagy. The company aims to create novel treatments for rare genetic and neurodegenerative diseases through its pipeline, which involves compound identification, chemical optimization, and in vivo validation across various species.

Laserhub

Series B in 2022
Laserhub GmbH is a Stuttgart-based company founded in 2017 that specializes in the production and distribution of custom-made metal parts. It operates as a leading procurement platform for industrial B2B customers in Germany, Austria, France, and Belgium. The company offers a range of services including laser cutting, bending, folding, deburring, thread cutting, powder coating, and laser engraving for materials such as steel, stainless steel, aluminum, and copper. Laserhub's innovative marketplace digitizes and automates procurement processes, allowing manufacturing companies to efficiently manage orders for sheet metal, turning, and milling parts. This approach helps to reduce both process and parts costs for its clients.

Refurbed

Series A in 2020
Refurbed GmbH is an online marketplace based in Vienna, Austria, specializing in the distribution of refurbished electronic goods. Founded in 2017, the company offers a range of products including phones, TVs, tablets, smart watches, laptops, desktops, headphones, consoles, cameras, and kitchen appliances. Refurbed devices undergo a rigorous 40-step renewal process to ensure they look new and function like new. Each device comes with at least a 12-month guarantee. The company aims to provide products that are up to 40% cheaper and 100% more environmentally friendly than brand-new counterparts, making it an attractive option for cost-conscious and eco-friendly consumers.

Samsara Therapeutics

Seed Round in 2018
Samsara Therapeutics, founded in 2018 with operations across Europe and San Diego, is a biopharmaceutical company dedicated to discovering and developing therapeutics for age-related diseases and unmet medical needs. Its proprietary platform focuses on identifying and validating compounds that extend healthy lifespan by targeting fundamental aging processes such as proteostasis and autophagy. The company aims to create novel treatments for rare genetic and neurodegenerative diseases through its pipeline, which involves compound identification, chemical optimization, and in vivo validation across various species.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.